HeimOPL • ASX
add
Opyl Ltd
Við síðustu lokun
0,018 $
Árabil
0,014 $ - 0,042 $
Markaðsvirði
3,07 m. AUD
Meðalmagn
66,80 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
ASX
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (AUD) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 76,98 þ. | -53,11% |
Rekstrarkostnaður | 421,40 þ. | 55,20% |
Nettótekjur | -927,04 þ. | -67,65% |
Hagnaðarhlutfall | -1,20 þ. | -257,51% |
Hagnaður á hvern hlut | — | — |
EBITDA | -909,06 þ. | -66,48% |
Virkt skatthlutfall | — | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (AUD) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 374,64 þ. | -17,27% |
Heildareignir | 411,60 þ. | -41,99% |
Heildarskuldir | 501,76 þ. | -54,93% |
Eigið fé alls | -90,16 þ. | — |
Útistandandi hlutabréf | 222,15 m. | — |
Eiginfjárgengi | ∞ | — |
Arðsemi eigna | -556,44% | — |
Ávöxtun eigin fjár | 2.540,24% | — |
Peningaflæði
Breyting á handbæru fé
| (AUD) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | -927,04 þ. | -67,65% |
Handbært fé frá rekstri | -738,29 þ. | -58,54% |
Reiðufé frá fjárfestingum | -8,86 þ. | -7.807,14% |
Reiðufé frá fjármögnun | 642,12 þ. | 72,83% |
Breyting á handbæru fé | -105,03 þ. | -11,42% |
Frjálst peningaflæði | -171,58 þ. | 42,93% |
Um
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Stofnsett
2013
Vefsvæði
Starfsfólk
3
